Preoperative serum CA-125 levels in endometrial cancer

Journal of Pelvic Medicine and Surgery

Volumn 15, Issue 3, 2009, Pages 145-150

  Uharček, Peter ^a   Mlynček, Miloš ^a   Ravinger, Jozef ^a   Lajtman, Erik ^a  

^a FACULTY HOSPITAL   (Slovakia)

Author keywords

CA 125; Endometrial cancer; Prognostic factors; Survival

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOLOGY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS;

EID: 68049128300     PISSN: 15425983     EISSN: None     Source Type: Journal    
DOI: 10.1097/SPV.0b013e31819d61a1     Document Type: Article

References (18)

1. Redecha M, Nižňanská Z, Korbel' M. Occurence of malignant tumors of uterus in Slovakia in 1990-2000. Gynekol. Prax, 2004;2s:194-199.
2. Shepherd JH. Revised FIGO staging for gynaecological cancer. Brit J Obstet Gynaec. 1989;96:889-892.
3. Barakat RR, Park RC, Grigsby PW, Muss HD, Norris HJ. Corpus: epithelial tumors. In: Hoskins WJ, Perez CA, Young RC, (eds). Principles and practice of gynecologic oncology. ed 2. Philadelphia: Lippincott-Raven Publishers. 1997:859-896.
4. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol. Oncol. 1991;40:55-65.
5. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer (a GOG study). Cancer. 1987;60,2035-2041.
6. Boronow RC, Morrow CP, Creasman WT. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet. Gynecol. 1984;63,825-832.
7. Franchi M, Ghezzi F, Riva C, Miglierina M, Buttarelli M, Bolis P. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol. 2001;78:232-240.
8. Powell JL, Hill KA, Shiro BC, Diehl SJ, Gajewski WH. Preoperative serum CA12-5 levels in treating endometrial cancer. J Reprod Med. 2005;50:585-590.
9. Dotters DJ. Preoperative CA 125 in endometrial cancer: Is it useful? Am J Obstet Gynecol. 2000;182:1328-1334.
10. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol. 2006;85:1501-1505.
11. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985;151:1009-1015.
12. Michel G, Morice P, Castaigne D, lanoux P, Pautier P, Lhome C, Gerbaulet A, Duvillard P. Prognostic factors of cancer of the endometrium and therapeutic implications. Contracept Fertil Sex. 1998;26:452-456.
13. Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr. Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol. 1990;163:1204-1209.
14. Takeshima N, Shimizu Y, Umezawa S, Hirai Y, Chen JT, Fujimoto I, et al. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma. Gynecol Oncol. 1994;54:321-326.
15. Ebina Y, Sakuragi N, Hareyama H, Todo Y, Nomura E, Takeda M, Okamoto K, Yamada H, Yamamoto R, Fujimoto S. Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma. Acta Obstet Gynecol Scand. 2002;81:458-465.
16. Sood AK, Buller RE, Burger RA, Dawson JD, Sorosky JI, Berman M. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol. 1997;90:441-447.
17. Hsieh CH, ChangChien CC, Lin H, Huang EY, Huang CC, Lan KC, Chang SY. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol. 2002;86:28-33.
18. Takač I, Gorišek B. Serum CA 125 levels and lymph node metastasis in patients with endometrial cancer. Wien Klin Wochenschr. 2006;118:62-65.